Mutual of Omaha Life Insurance Fit Review for Kidney Disease

Research Snapshot

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

• Is Mutual of Omaha a good choice for Life Insurance for Kidney Disease?
• Why did Mutual of Omaha rank first for kidney disease life insurance when some platforms rated it only a mixed fit?

Mutual of Omaha qualified because every platform in this study named it during ranking discovery, and it finished first overall with an average listed rank of 3.29 ^[1]. It was the only carrier named by all seven platforms.

The qualification rests on product structure rather than price leadership. Mutual of Omaha advertises guaranteed whole life coverage with no medical exam, generally for ages 45–85, with coverage of $2,000–$25,000 and different rules in New York ^[5]. The company also identifies kidney problems as a condition commonly evaluated through a life-insurance medical exam, and describes guaranteed whole life as an alternative when medical underwriting is a concern ^[7].

Platform fit ratings were not unanimous. Kimi rated the fit "strong," Anthropic, DeepSeek, Google, and OpenAI rated it "good," and Grok and Perplexity rated it "mixed." That spread reflects a real split in the evidence: guaranteed acceptance is broadly confirmed, while kidney-stage-specific underwriting rules are not.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Kidney Disease

Questions This Section Answers

• Which Mutual of Omaha plan should a buyer with Stage 4-5 CKD or dialysis choose?
• Is Living Promise Whole Life or Guaranteed Whole Life the better fit for someone with chronic kidney disease?
• Does Mutual of Omaha offer term life insurance to applicants with kidney disease?

The most relevant products are Guaranteed Whole life insurance and Living Promise Whole Life, which is sold in Level Benefit and Graded Benefit versions ^[8].

Guaranteed Whole Life is the acceptance-focused path. Mutual of Omaha describes it as having no medical underwriting, fixed premiums, and a two-year limited benefit period ^[11]. The advertised quote path lists ages 45–85 and coverage of $2,000–$25,000, with different rules in Washington and New York ^[12].

Living Promise is the middle path. It uses simplified underwriting rather than guaranteed acceptance. The producer guide lists the level-benefit plan for ages 45–85 with face amounts up to $50,000, and the graded-benefit plan for ages 45–80 with face amounts up to $20,000, with state availability and limits subject to variation ^[10]. One consumer brochure states Living Promise uses simplified underwriting with no medical exam and only two health questions ^[13], while other independent guides describe a longer health-question set of roughly five to seven questions that lists chronic kidney disease specifically ^[14].

Term options exist but are a different underwriting path. Mutual of Omaha offers fully underwritten term life insurance requiring medical underwriting ^[15], and Term Life Express is a simplified-underwriting term product with a stated coverage range plus chronic illness and critical illness riders ^[16]. Accelerated underwriting for term and IUL is described in third-party producer materials as available only to eligible applicants, with ineligible-condition lists that include ratable medical conditions ^[17].

What the AI Platforms Agreed About

Questions This Section Answers

• Do all AI platforms agree that Mutual of Omaha accepts kidney disease applicants?
• What do reviewers agree is the biggest drawback of Mutual of Omaha for kidney disease life insurance?

Platforms agreed on four points.

First, guaranteed-issue availability. Mutual of Omaha describes a whole life product with guaranteed acceptance that does not require answering health questions, subject to age and eligibility rules ^[18]. Independent analysis identifies the company as offering the best guaranteed-issue option for people on dialysis or with advanced kidney disease, with coverage for ages 45–85 ^[19].

Second, the graded-benefit tradeoff. Guaranteed whole life has a two-year limited benefit period: for nonaccidental death during the first two years, the beneficiary receives 110% of premiums paid, while accidental death receives the full face amount and full benefits apply after two years ^[22]. Independent guides describe the same two-year waiting period for the graded plan, with premiums plus 10% payable for natural-cause death inside that window ^[23].

Third, coverage scale. The guaranteed-issue product is positioned for final expenses, burial costs, debts, or a small legacy, and its advertised face-amount range is generally too small for major income-replacement or mortgage-protection needs ^[22]. Independent sources put guaranteed-issue caps at $25,000 and simplified-issue caps at roughly $40,000–$50,000 depending on the source ^[26].

Fourth, financial strength. Mutual of Omaha holds an A+ (Superior) financial strength rating from AM Best and scored 707/1000 in J.D. Power's 2025 U.S. Life Insurance Study, ranking first among 23 insurers and 57 points above the industry average of 650 ^[28]. These are independent ratings of the company, not evidence that the product is the best value for kidney disease.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Does Mutual of Omaha guarantee acceptance for Stage 4-5 CKD or dialysis patients?
• Will a kidney disease applicant get Living Promise Level Benefit or Graded Benefit?
• Is Mutual of Omaha's kidney disease life insurance expensive compared with other carriers?

The largest disagreement concerns stage-specific acceptance. The supplied description refers to "Mutual of Omaha Guaranteed Issue Whole Life for Stage 4-5 CKD or dialysis patients" and "Simplified Issue for Stage 3-4," but no official public life-underwriting source reviewed confirms those stage-specific classifications ^[30]. Perplexity stated that the supplied ranking-stage mention of a guaranteed-issue option for stage 4-5 CKD or dialysis was not verified in publicly checked sources and should be treated as unconfirmed.

Level versus graded placement is also unresolved. CKD diagnosis in the past four years triggers graded-benefit placement rather than level benefit according to health-question guidelines, and end-stage renal disease and dialysis are specifically listed health questions ^[31]. Some sources note underwriting can be unpredictable and applicants with similar profiles sometimes receive different tier placements ^[33]. Google reported that any active renal disease, dialysis, or diabetic nephropathy will disqualify applicants from the Living Promise Level Benefit plan ^[34].

Dialysis handling conflicts across platforms. Grok reported that dialysis or ESRD typically declines Living Promise Level and Graded, leaving guaranteed issue as the fallback ^[36]. Kimi reported that simplified issue has very low approval for dialysis and that guaranteed issue is the primary viable option ^[38]. Perplexity reported that public materials do not verify a CKD-specific guaranteed-issue path at all.

Pricing evidence is thin and inconsistent. Policygenius analysis indicates Mutual of Omaha guaranteed-issue policies are more expensive than average versus competitors, while still rating the company best overall for dialysis patients ^[39]. One independent analysis cites roughly $99 per month for a 50-year-old male and under $75 per month for a 50-year-old female for $25,000 of guaranteed-issue coverage ^[40]. Another source cites a $50–$150 monthly range for $10,000–$25,000 of guaranteed-issue coverage for ages 45–60 on dialysis ^[41]. These are platform-reported sample figures, not published rate cards.

Face-amount limits also conflict. The currently advertised guaranteed whole-life quote path shows $2,000–$25,000, while an older Living Promise producer guide lists different limits, including up to $50,000 for the level-benefit plan; the applicable state, policy version, and distribution channel must be verified ^[42].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• Does Mutual of Omaha's critical illness rider cover kidney failure?
• Can a Mutual of Omaha whole life policy for kidney disease build cash value?
• Does Mutual of Omaha require a medical exam for kidney disease applicants?

The features most relevant to a kidney-disease buyer are underwriting access, benefit structure, and riders.

Underwriting access: Guaranteed Whole Life requires no medical underwriting ^[44]. Living Promise uses simplified underwriting with no medical exam ^[45]. Fully underwritten term and universal life products assess kidney health using blood and urinalysis testing, looking at creatinine, BUN, and urine protein levels to set premium rates ^[47].

Benefit structure: Whole life policies build cash value over time that grows tax-deferred, and the policyholder can borrow against or withdraw accumulated cash value, though it takes years for cash value to reach significant amounts ^[49]. Guaranteed whole life is described as guaranteed to age 100 while premiums are paid, with the policy form and state-specific contract controlling ^[44].

Riders: A critical illness rider covers kidney failure and allows early access to death benefits, with availability varying by state ^[51]. The Living Promise producer guide lists an accelerated death benefit rider for the level-benefit plan and no riders for the graded-benefit plan, with state variations applying ^[53]. One consumer brochure states an accelerated death benefit rider for terminal illness is included at no extra cost on eligible Living Promise plans ^[54].

Sales channel: Living Promise is sold only through licensed agents, not online, by mail, or by calling the company directly ^[55]. This matters for buyers who want instant online quotes.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Mutual of Omaha guaranteed issue whole life cost per month for a 50-year-old with kidney disease?
• What policy fees and loan charges apply to Mutual of Omaha Living Promise Whole Life?
• Are Mutual of Omaha whole life premiums guaranteed never to increase?

No verified public kidney-disease-specific premium schedule exists. Individual premiums require a quote, and public materials verify fixed-premium whole-life positioning and product fees but not a dependable CKD-specific price ^[57].

Documented fees and charges from the Living Promise producer guide: a $36 annual policy fee for the level-benefit plan, a $12 annual policy fee for the graded-benefit plan, and policy loans charged at 7.4% in advance ^[59].

Platform-reported sample premiums, which are not published rate cards:

Sources: ^[60].

Contract terms reported by platforms: premiums are level and guaranteed never to increase; the death benefit is guaranteed and never decreases; a 30-day free look allows cancellation with a full refund of premiums paid; a grace period of roughly 30 days applies for missed payments; and reinstatement after lapse may require proof of insurability ^[64]. Mutual of Omaha states that whole-life pricing depends on factors including age, sex, and death-benefit amount and that premiums are not generally increased ^[58].

Guaranteed issue generally costs more per dollar of coverage than medically underwritten insurance because acceptance is not based on health history ^[66]. Independent analysis notes Mutual of Omaha typically prices on the lower end of the market for $10,000–$50,000 final expense coverage, while term pricing runs 2–6% above national averages ^[67].

Best Suited For

Questions This Section Answers

• Who is Mutual of Omaha best for among kidney disease life insurance buyers?
• Is Mutual of Omaha a good fit for a dialysis patient who needs final expense coverage?

Mutual of Omaha is best suited to applicants with advanced, unstable, or poorly documented kidney disease who need final-expense or small permanent coverage, and who fall within the product age limits ^[68].

Specific buyer profiles supported by the evidence:

• Adults ages 45–85 with Stage 4–5 CKD or on dialysis seeking final expense coverage ^[70].
• Applicants with chronic kidney disease history who cannot qualify for traditional term or fully underwritten whole life ^[72].
• Consumers wanting permanent, lifetime coverage with level premiums that never increase ^[73].
• Individuals needing relatively small death benefits in the $2,000–$25,000 range for funeral or final expenses ^[74].
• Applicants with milder or stable kidney impairment who should first test simplified-issue or fully underwritten options ^[75].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Mutual of Omaha for Life Insurance for Kidney Disease?
• Is Mutual of Omaha a bad choice for a buyer who needs more than $25,000 of coverage?

Mutual of Omaha is probably not best suited to buyers who need substantial coverage, want the lowest possible premium, or may qualify for medically underwritten term or simplified-issue coverage with better economics ^[77].

Specific exclusions supported by the evidence:

• Buyers needing more than approximately $25,000 of guaranteed-issue coverage through the currently advertised online product ^[79].
• Younger applicants outside the guaranteed-issue product's stated age range of 45–85 ^[79].
• Applicants seeking income replacement, mortgage protection, or large estate-liquidity coverage ^[78].
• Applicants who can qualify for competitively priced term life or medically underwritten permanent insurance ^[81].
• Buyers who cannot tolerate a two-year graded-benefit waiting period ^[82].
• Buyers who want instant online quotes without agent contact, since Living Promise is agent-only ^[83].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Mutual of Omaha for a kidney disease buyer who needs more than $25,000 of coverage?
• When should a kidney disease applicant skip Mutual of Omaha and use a broker instead?

Another option may be better in these situations, as reported by the platforms:

• A licensed broker can obtain medically underwritten term quotes from multiple carriers for stable stage 1–3 CKD or resolved kidney impairment ^[84].
• The buyer needs substantially more coverage than guaranteed-issue limits provide ^[86].
• The buyer is younger than the guaranteed-issue eligibility range ^[86].
• The buyer can qualify for simplified-issue or fully underwritten coverage with a level benefit and no graded period ^[88].
• Employer group life insurance is available with limited or no individual medical underwriting ^[90].
• The buyer wants published CKD-specific underwriting guidance before applying ^[91].
• The buyer is post-transplant with stable function and may qualify for fully underwritten term at better rates and higher limits ^[90].

For buyers comparing across carriers, the broader Life Insurance for Kidney Disease index covers the full field of carriers evaluated in this study.

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Mutual of Omaha before signing a kidney disease life insurance contract?
• How can a buyer confirm whether their CKD stage qualifies for Level Benefit or Graded Benefit?

The platforms converged on a verification checklist. Buyers should confirm each item directly with the insurer or a broker before purchasing.

• Which exact policy form and underwriting company apply in the buyer's state ^[93].
• Whether the application is truly guaranteed issue, or includes health questions, prescription checks, MIB review, or telephone underwriting ^[95].
• The eligibility rules for dialysis, kidney transplant, nephrectomy, polycystic kidney disease, acute kidney injury, and CKD stages 1–5 ^[97].
• How eGFR, creatinine, proteinuria, cause of CKD, progression, diabetes, hypertension, and recent hospitalizations affect the offer ^[99].
• The exact face-amount limit and age range in the buyer's state ^[93].
• Whether the death benefit is level or graded, and precisely what is payable during the first two policy years ^[95].
• The monthly or annual premiums, policy fees, payment schedule, lapse rules, and guaranteed cash values ^[103].
• Whether accelerated-benefit riders are included, optional, excluded, or unavailable in the buyer's state ^[103].
• Whether a broker's comparison of term, simplified-issue, employer group, and guaranteed-issue policies would produce better coverage or pricing ^[103].
• Whether replacing existing kidney-related coverage would create a new contestability or graded-benefit period ^[95].

Final AI Consensus Verdict

Mutual of Omaha is a good fit for acceptance-focused final-expense coverage when kidney disease may prevent conventional approval, but it is not clearly the best overall value. All seven platforms named it in the ranking stage, and it finished first with an average listed rank of 3.29.

The consensus case is straightforward: guaranteed-issue whole life remains available when CKD or dialysis makes conventional underwriting difficult, and Living Promise creates a possible middle path for applicants with manageable health histories ^[106]. Independent reviewers repeatedly identify the company as a leading guaranteed-issue option for dialysis and advanced kidney disease ^[110].

The consensus caution is equally clear. Most kidney-disease applicants land in a graded-benefit tier with a two-year waiting period, coverage caps near $25,000, and premiums that independent analysis describes as higher than average for guaranteed issue ^[113]. Stage-specific acceptance rules are not verified in public company materials, and platform fit ratings split between good, strong, and mixed.

The practical verdict: test Living Promise simplified issue or fully underwritten alternatives first if kidney function is stable and coverage needs exceed a small permanent benefit. Select guaranteed issue only after comparing premium, the two-year graded benefit, state-specific terms, and available alternatives.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms evaluated Mutual of Omaha for the specific use case of life insurance for kidney disease: Anthropic (claude-haiku-4-5-20251001), DeepSeek (deepseek-v4-flash), Google (gemini-3.5-flash), Grok (x-ai/grok-4.3), Kimi (moonshotai/kimi-k2.6), OpenAI (gpt-5.6-luna), and Perplexity (perplexity/sonar).

Each platform returned a fit rating, a direct answer, strengths and limitations, use-case findings, pricing and terms, and questions to verify before buying. All seven platforms named Mutual of Omaha during ranking discovery, giving it a 100% platform share and a first-place final rank.

Citations in this review are platform-reported evidence, not independently verified facts. Company-owned sources are labeled as owned; independent reviews are labeled as independent. Where a platform supplied no citation for a factual claim, the claim is labeled platform-reported.

Methodology Limitations

Several limitations apply to this review.

Platform-reported research dates differ from the authoritative run date. DeepSeek reported a research date of 2026-06-01, while the other six platforms and the run itself are dated 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

No public source reviewed establishes a guaranteed acceptance outcome for any particular CKD diagnosis ^[114]. The supplied description of stage-specific guaranteed-issue and simplified-issue classifications for CKD stages 3–5 is not confirmed by an official public life-underwriting source.

Public evidence does not verify acceptance or pricing for particular CKD stages, dialysis, transplant history, eGFR, creatinine, proteinuria, or comorbidities ^[114]. A company kidney-risk table located in the research concerns a long-term-care guide, not the life-insurance products evaluated here, so it should not be treated as a life-underwriting rule ^[114].

Product labels supplied for this assessment include several descriptions that could refer to different versions or distribution channels; exact state-specific product identity must be confirmed ^[116].

Living Promise simplified underwriting is not the same as guaranteed acceptance and may still decline or restrict applicants based on health answers or prescription data ^[118].

United of Omaha Life Insurance Company is the stated underwriter for many products, while New York uses a different underwriting-company arrangement; state-specific availability is unclear without the applicant's state ^[116].

Platform agreement on a carrier's inclusion does not prove product quality, and no platform in this study conducted independent verification of the other platforms' claims.